TendoNova
Atlanta, US · Founded 2017 · 3 known investors
TendoNova develops microinvasive medical technology, including its Ocelot Nano device, to treat chronic tendon pain in patients. The company targets clinical use for patients with tendon injuries, including athletes.
Founders & leadership
IC
Ian CampbellinInvestor & Board Member
MS
Mark SamuelsNamed on SEC filing
LM
Louis MaliceNamed on SEC filing
LG
Luka GrujicNamed on SEC filing
SK
Shawna KhouriNamed on SEC filing
BR
Brett RogersNamed on SEC filing
Board
JC
Jeff ClarkBoard director
JS
Jonathan ShawBoard director
PH
Investors · 3
Reported raises · per SEC filings
Form D private placements$3.8M disclosed across 7 rounds · 2019–2024
▶$270KraisedAug 2024 · 3 investors · BiotechnologyRule 506(b)
▶$270KraisedAug 2024 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeff ClarkDirector
- Jonathan ShawDirector
- Ian CampbellExecutive Officer, Director
- Peter HaalandDirector
- Offering amount
- $400K
- Amount sold
- $270K
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$762KraisedMay 2024 · 6 investors · BiotechnologyRule 506(b)
▶$762KraisedMay 2024 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan ShawDirector
- Jeff ClarkDirector
- Mark SamuelsExecutive Officer, Director
- Ian CampbellDirector
- Peter HaalandDirector
- Offering amount
- $1.1M
- Amount sold
- $762K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250KraisedJan 2024 · 10 investors · BiotechnologyRule 506(b)
▶$250KraisedJan 2024 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawna KhouriDirector
- Mark SamuelsExecutive Officer, Director
- Jonathan ShawDirector
- Luka GrujicDirector
- Peter HaalandDirector
- Brett RogersDirector
- Louis MaliceDirector
- Offering amount
- $500K
- Amount sold
- $250K
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedOct 2023 · 3 investors · BiotechnologyRule 506(b)
▶$300KraisedOct 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Luka GrujicDirector
- Jonathan ShawDirector
- Peter HaalandDirector
- Louis MaliceDirector
- Shawna KhouriDirector
- Brett RogersDirector
- Mark SamuelsExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$440KraisedDec 2022 · 8 investors · BiotechnologyRule 506(b)
▶$440KraisedDec 2022 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Luka GrujicDirector
- Shawna KhouriDirector
- Jonathan ShawDirector
- Louis MaliceDirector
- Peter HaalandDirector
- Brett RogersDirector
- Mark SamuelsExecutive Officer, Director
- Offering amount
- $700K
- Amount sold
- $440K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$446.3KraisedAug 2022 · 11 investors · BiotechnologyRule 506(b)
▶$446.3KraisedAug 2022 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan ShawDirector
- Shawna KhouriDirector
- Luka GrujicDirector
- Brett RogersDirector
- Louis MaliceDirector
- Mark SamuelsExecutive Officer, Director
- Peter HaalandDirector
- Offering amount
- $2M
- Amount sold
- $446.3K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.4MraisedFeb 2021 · 13 investors · BiotechnologyRule 506(b)
▶$1.4MraisedFeb 2021 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark SamuelsExecutive Officer
- Peter HaalandDirector
- Jonathan ShawExecutive Officer, Director
- Louis MaliceDirector
- Luka GrujicDirector
- Shawna KhouriDirector
- Brett RogersDirector
- Offering amount
- $1.5M
- Amount sold
- $1.4M
- Minimum investment
- $10K
- Proceeds to insiders
- $50K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Doximity54 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Sharecare29 shared keywordsSharecare provides AI-powered health navigation for employers and health plans, connecting employees' health questions to their available benefits and appropriate care options. The platform surfaces relevant wellness programs, chronic condition management, and advocacy services within employees' moment of need.
Practo28 shared keywordsPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
Read the Press Release25 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Zocdoc23 shared keywordsZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.
Companies competing with TendoNova for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does TendoNova do?
- TendoNova develops microinvasive medical technology, including its Ocelot Nano device, to treat chronic tendon pain in patients. The company targets clinical use for patients with tendon injuries, including athletes.
- Who are TendoNova's investors?
- TendoNova's investors include Walnut Venture Associates, InnerProduct Partners, VentureSouth.
- How much funding has TendoNova raised?
- TendoNova has disclosed $3.8M raised across 7 rounds.
- Where is TendoNova headquartered?
- TendoNova is headquartered in Atlanta, US.